Ken Griffin’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-73,686
Closed -$24.3K 13825
2025
Q4
$24.3K Buy
73,686
+266
+0.4% +$58 ﹤0.01% 12290
2025
Q3
$14.8K Sell
73,420
-125
-0.2% -$26 ﹤0.01% 12535
2025
Q2
$19.9K Sell
73,545
-6
-0% -$1 ﹤0.01% 12110
2025
Q1
$23.5K Sell
73,551
-408
-0.6% -$104 ﹤0.01% 13028
2024
Q4
$17K Sell
73,959
-1,750
-2% -$226 ﹤0.01% 13278
2024
Q3
$7.41K Sell
75,709
-3,737
-5% -$654 ﹤0.01% 13365
2024
Q2
$12.7K Sell
79,446
-11,648
-13% -$2.38K ﹤0.01% 12972
2024
Q1
$27.6K Buy
91,094
+17,349
+24% +$2.06K ﹤0.01% 12769
2023
Q4
$4.42K Buy
73,745
+432
+0.6% +$24 ﹤0.01% 13507
2023
Q3
$7.33K Sell
73,313
-45
-0.1% -$6 ﹤0.01% 13264
2023
Q2
$12.1K Sell
73,358
-1,700
-2% -$266 ﹤0.01% 13096
2023
Q1
$9.01K Buy
75,058
+1,336
+2% +$220 ﹤0.01% 13612
2022
Q4
$10.7K Buy
73,722
+296
+0.4% +$40 ﹤0.01% 13609
2022
Q3
$15K Sell
73,426
-289
-0.4% -$83 ﹤0.01% 12163
2022
Q2
$21K Buy
73,715
+109
+0.1% +$70 ﹤0.01% 12385
2022
Q1
$59K Buy
73,606
+187
+0.3% +$188 ﹤0.01% 12695
2021
Q4
$139K Sell
73,419
-85
-0.1% -$193 ﹤0.01% 12368
2021
Q3
$188K Sell
73,504
-209
-0.3% -$489 ﹤0.01% 12074
2021
Q2
$192K Hold
73,713
﹤0.01% 12206
2021
Q1
$197K Buy
+73,713
New +$213K ﹤0.01% 11720

Ken Griffin's NUVB.WS Position: Q1 2026 in Review

Ken Griffin sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 73,686 shares — an estimated $24.3K sold.

Ken Griffin first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $197K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

  • Ken Griffin reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 73,686 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $24.3K.
  • Ken Griffin first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
  • Ken Griffin's Nuvation Bio Inc Warrants position peaked at $197K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.